{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T02:16:13Z","timestamp":1775787373382,"version":"3.50.1"},"reference-count":105,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Initial Scientific Research Fund of Guangxi University of Chinese Medicine","award":["2017BS014"],"award-info":[{"award-number":["2017BS014"]}]},{"name":"the Natural Science Foundation of Guangxi Zhuang Autonomous Region","award":["2025GXNSFAA069334"],"award-info":[{"award-number":["2025GXNSFAA069334"]}]},{"name":"the Foundation of Guangxi Key Laboratory of Marine Drugs","award":["LMD2023-4"],"award-info":[{"award-number":["LMD2023-4"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Histol"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s10735-025-10683-1","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T02:19:21Z","timestamp":1767752361000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["YY1 in prostate cancer: multidimensional oncogenicmechanisms and emerging therapeutic vulnerabilities"],"prefix":"10.1007","volume":"57","author":[{"given":"Qiuyu","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongxiu","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruyan","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linjian","family":"Mo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yonghong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueni","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,7]]},"reference":[{"issue":"9","key":"10683_CR1","doi-asserted-by":"publisher","first-page":"3565","DOI":"10.1128\/MCB.26.9.3565-3581.2006","volume":"26","author":"B Affar el","year":"2006","unstructured":"Affar el B, Gay F, Shi Y, Liu H, Huarte M, Wu S, Collins T, Li E, Shi Y (2006) Essential dosage-dependent functions of the transcription factor Yin Yang 1 in late embryonic development and cell cycle progression. Mol Cell Biol 26(9):3565\u20133581. https:\/\/doi.org\/10.1128\/MCB.26.9.3565-3581.2006","journal-title":"Mol Cell Biol"},{"issue":"1","key":"10683_CR2","doi-asserted-by":"publisher","first-page":"R9","DOI":"10.1186\/bcr1851","volume":"10","author":"A Allouche","year":"2008","unstructured":"Allouche A, Nolens G, Tancredi A, Delacroix L, Mardaga J, Fridman V, Winkler R, Boniver J, Delvenne P, Begon DY (2008) The combined immunodetection of AP-2alpha and YY1 transcription factors is associated with ERBB2 gene overexpression in primary breast tumors. Breast Cancer Res 10(1):R9. https:\/\/doi.org\/10.1186\/bcr1851","journal-title":"Breast Cancer Res"},{"issue":"14","key":"10683_CR4","doi-asserted-by":"publisher","first-page":"7767","DOI":"10.3390\/ijms25147767","volume":"25","author":"G Antonio-Andres","year":"2024","unstructured":"Antonio-Andres G, Morales-Martinez M, Jimenez-Hernandez E, Huerta-Yepez S (2024) The role of PTEN in chemoresistance mediated by the HIF-1\u03b1\/YY1 axis in pediatric acute lymphoblastic leukemia. Int J Mol Sci 25(14):7767. https:\/\/doi.org\/10.3390\/ijms25147767","journal-title":"Int J Mol Sci"},{"issue":"11","key":"10683_CR3","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1080\/10428194.2018.1448083","volume":"59","author":"G Antonio-Andr\u00e9s","year":"2018","unstructured":"Antonio-Andr\u00e9s G, Rangel-Santiago J, Tirado-Rodr\u00edguez B, Martinez-Ruiz GU, Klunder-Klunder M, Vega MI, Lopez-Martinez B, Jim\u00e9nez-Hern\u00e1ndez E, Torres Nava J, Medina-Sanson A, Huerta-Yepez S (2018) Role of Yin Yang-1 (YY1) in the transcription regulation of the multi-drug resistance (MDR1) gene. Leuk Lymphoma 59(11):2628\u20132638. https:\/\/doi.org\/10.1080\/10428194.2018.1448083","journal-title":"Leuk Lymphoma"},{"issue":"8","key":"10683_CR5","doi-asserted-by":"publisher","first-page":"5441","DOI":"10.4049\/jimmunol.179.8.5441","volume":"179","author":"S Baritaki","year":"2007","unstructured":"Baritaki S, Katsman A, Chatterjee D, Yeung KC, Spandidos DA, Bonavida B (2007) Regulation of tumor cell sensitivity to TRAIL-induced apoptosis by the metastatic suppressor Raf kinase inhibitor protein via Yin Yang 1 inhibition and death receptor 5 up-regulation. J Immunol 179(8):5441\u20135453. https:\/\/doi.org\/10.4049\/jimmunol.179.8.5441","journal-title":"J Immunol"},{"issue":"26","key":"10683_CR6","doi-asserted-by":"publisher","first-page":"24428","DOI":"10.1074\/jbc.M503790200","volume":"280","author":"DY Begon","year":"2005","unstructured":"Begon DY, Delacroix L, Vernimmen D, Jackers P, Winkler R (2005) Yin Yang 1 cooperates with activator protein 2 to stimulate ERBB2 gene expression in mammary cancer cells. J Biol Chem 280(26):24428\u201324434. https:\/\/doi.org\/10.1074\/jbc.M503790200","journal-title":"J Biol Chem"},{"issue":"3","key":"10683_CR7","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1080\/15548627.2016.1268300","volume":"13","author":"AM Blessing","year":"2017","unstructured":"Blessing AM, Rajapakshe K, Reddy Bollu L, Shi Y, White MA, Pham AH, Lin C, Jonsson P, Cortes CJ, Cheung E, La Spada AR, Bast RC Jr, Merchant FA, Coarfa C, Frigo DE (2017) Transcriptional regulation of core autophagy and lysosomal genes by the androgen receptor promotes prostate cancer progression. Autophagy 13(3):506\u2013521. https:\/\/doi.org\/10.1080\/15548627.2016.1268300","journal-title":"Autophagy"},{"key":"10683_CR8","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.pharmthera.2015.01.011","volume":"150","author":"B Bonavida","year":"2015","unstructured":"Bonavida B, Kaufhold S (2015) Prognostic significance of YY1 protein expression and mRNA levels by bioinformatics analysis in human cancers: a therapeutic target. Pharmacol Ther 150:149\u2013168. https:\/\/doi.org\/10.1016\/j.pharmthera.2015.01.011","journal-title":"Pharmacol Ther"},{"issue":"2","key":"10683_CR9","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.cyto.2011.06.024","volume":"56","author":"S Caggia","year":"2011","unstructured":"Caggia S, Libra M, Malaponte G, Cardile V (2011) Modulation of YY1 and p53 expression by transforming growth factor-\u03b23 in prostate cell lines. Cytokine 56(2):403\u2013410. https:\/\/doi.org\/10.1016\/j.cyto.2011.06.024","journal-title":"Cytokine"},{"issue":"3","key":"10683_CR10","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.bbrc.2018.12.056","volume":"508","author":"B Camacho-Moctezuma","year":"2019","unstructured":"Camacho-Moctezuma B, Quevedo-Castillo M, Melendez-Zajgla J, Aquino-Jarquin G, Martinez-Ruiz GU (2019) YY1 negatively regulates the XAF1 gene expression in prostate cancer. Biochem Biophys Res Commun 508(3):973\u2013979. https:\/\/doi.org\/10.1016\/j.bbrc.2018.12.056","journal-title":"Biochem Biophys Res Commun"},{"issue":"9","key":"10683_CR11","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.4161\/cc.8.9.8314","volume":"8","author":"G Castellano","year":"2009","unstructured":"Castellano G, Torrisi E, Ligresti G, Malaponte G, Militello L, Russo AE, McCubrey JA, Canevari S, Libra M (2009) The involvement of the transcription factor Yin Yang 1 in cancer development and progression. Cell Cycle 8(9):1367\u20131372. https:\/\/doi.org\/10.4161\/cc.8.9.8314","journal-title":"Cell Cycle"},{"key":"10683_CR12","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.canlet.2019.07.019","volume":"463","author":"Q Chen","year":"2019","unstructured":"Chen Q, Zhang J-J, Ge W-L, Chen L, Yuan H, Meng L-D, Huang X-M, Shen P, Miao Y, Jiang K-R (2019) YY1 inhibits the migration and invasion of pancreatic ductal adenocarcinoma by downregulating the FER\/STAT3\/MMP2 signaling pathway. Cancer Lett 463:37\u201349. https:\/\/doi.org\/10.1016\/j.canlet.2019.07.019","journal-title":"Cancer Lett"},{"issue":"4","key":"10683_CR13","doi-asserted-by":"publisher","first-page":"e006020","DOI":"10.1136\/jitc-2022-006020","volume":"11","author":"S Chen","year":"2023","unstructured":"Chen S, Lu K, Hou Y, You Z, Shu C, Wei X, Wu T, Shi N, Zhang G, Wu J, Chen S, Zhang L, Li W, Zhang D, Ju S, Chen M, Xu B (2023) YY1 complex in M2 macrophage promotes prostate cancer progression by upregulating IL-6. J Immunother Cancer 11(4):e006020. https:\/\/doi.org\/10.1136\/jitc-2022-006020","journal-title":"J Immunother Cancer"},{"issue":"16","key":"10683_CR14","doi-asserted-by":"publisher","first-page":"7260","DOI":"10.1128\/MCB.24.16.7260-7274.2004","volume":"24","author":"L Cicatiello","year":"2004","unstructured":"Cicatiello L, Addeo R, Sasso A, Altucci L, Petrizzi VB, Borgo R, Cancemi M, Caporali S, Caristi S, Scafoglio C, Teti D, Bresciani F, Perillo B, Weisz A (2004) Estrogens and progesterone promote persistent CCND1 gene activation during G1 by inducing transcriptional derepression via c-Jun\/c-Fos\/estrogen receptor (progesterone receptor) complex assembly to a distal regulatory element and recruitment of cyclin D1 to its own gene promoter. Mol Cell Biol 24(16):7260\u20137274. https:\/\/doi.org\/10.1128\/MCB.24.16.7260-7274.2004","journal-title":"Mol Cell Biol"},{"issue":"15","key":"10683_CR15","doi-asserted-by":"publisher","first-page":"287","DOI":"10.21037\/atm.2016.07.22","volume":"4","author":"GA Clawson","year":"2016","unstructured":"Clawson GA (2016) Histone deacetylase inhibitors as cancer therapeutics. Ann Transl Med 4(15):287. https:\/\/doi.org\/10.21037\/atm.2016.07.22","journal-title":"Ann Transl Med"},{"issue":"18","key":"10683_CR16","doi-asserted-by":"publisher","first-page":"3705","DOI":"10.1093\/nar\/25.18.3705","volume":"25","author":"EG Cole","year":"1997","unstructured":"Cole EG, Gaston K (1997) A functional YY1 binding site is necessary and sufficient to activate Surf-1 promoter activity in response to serum growth factors. Nucleic Acids Res 25(18):3705\u20133711. https:\/\/doi.org\/10.1093\/nar\/25.18.3705","journal-title":"Nucleic Acids Res"},{"issue":"42","key":"10683_CR19","doi-asserted-by":"publisher","first-page":"3746","DOI":"10.1038\/onc.2009.231","volume":"28","author":"Z Deng","year":"2009","unstructured":"Deng Z, Wan M, Cao P, Rao A, Cramer SD, Sui G (2009) Yin Yang 1 regulates the transcriptional activity of androgen receptor. Oncogene 28(42):3746\u20133757. https:\/\/doi.org\/10.1038\/onc.2009.231","journal-title":"Oncogene"},{"issue":"3","key":"10683_CR18","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/sj.onc.1209804","volume":"26","author":"F de Nigris","year":"2006","unstructured":"de Nigris F, Botti C, Rossiello R, Crimi E, Sica V, Napoli C (2006) Cooperation between Myc and YY1 provides novel silencing transcriptional targets of alpha3beta1-integrin in tumour cells. Oncogene 26(3):382\u2013394. https:\/\/doi.org\/10.1038\/sj.onc.1209804","journal-title":"Oncogene"},{"issue":"32","key":"10683_CR102","doi-asserted-by":"publisher","first-page":"14484","DOI":"10.1073\/PNAS.1008256107","volume":"107","author":"F de Nigris","year":"2010","unstructured":"de Nigris F, Crudele V, Giovane A, Casamassimi A, Giordano A, Garban HJ, Cacciatore F, Pentimalli F, Marquez-Garban DC, Petrillo A, Cito L, Sommese L, Fiore A, Petrillo M, Siani A, Barbieri A, Arra C, Rengo F, Hayashi T, Al-Omran M, Ignarro LJ, Napoli C (2010) CXCR4\/YY1 inhibition impairs VEGF network and angiogenesis during malignancy. Proc Natl Acad Sci U S A 107(32): 14484\u201314489. https:\/\/doi.org\/10.1073\/PNAS.1008256107","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"10683_CR20","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/s41419-019-1707-x","volume":"10","author":"W Di","year":"2019","unstructured":"Di W, Weinan X, Xin L, Zhiwei Y, Xinyue G, Jinxue T, Mingqi L (2019) Long noncoding RNA SNHG14 facilitates colorectal cancer metastasis through targeting EZH2-regulated EPHA7. Cell Death Dis 10(7):514. https:\/\/doi.org\/10.1038\/s41419-019-1707-x","journal-title":"Cell Death Dis"},{"issue":"5","key":"10683_CR21","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/s41580-023-00694-9","volume":"25","author":"J Ferrer","year":"2024","unstructured":"Ferrer J, Dimitrova N (2024) Transcription regulation by long non-coding RNAs: mechanisms and disease relevance. Nat Rev Mol Cell Biol 25(5):396\u2013415. https:\/\/doi.org\/10.1038\/s41580-023-00694-9","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1\u20132","key":"10683_CR22","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1615\/CritRevOncog.2017020836","volume":"22","author":"NR Galloway","year":"2017","unstructured":"Galloway NR, Ball KF, Stiff T, Wall NR (2017) Yin Yang 1 (YY1): regulation of survivin and its role in invasion and metastasis. Crit Rev Oncog 22(1\u20132):23\u201336. https:\/\/doi.org\/10.1615\/CritRevOncog.2017020836","journal-title":"Crit Rev Oncog"},{"issue":"22","key":"10683_CR23","doi-asserted-by":"publisher","first-page":"4229","DOI":"10.1111\/febs.14665","volume":"285","author":"D Gao","year":"2018","unstructured":"Gao D, Wang L, Zhang H, Yan X, Yang J, Zhou R, Chang X, Sun Y, Tian S, Yao Z, Zhang K, Liu Z, Ma Z (2018) Spleen tyrosine kinase SYK(L) interacts with YY1 and coordinately suppresses SNAI2 transcription in lung cancer cells. FEBS J 285(22):4229\u20134245. https:\/\/doi.org\/10.1111\/febs.14665","journal-title":"FEBS J"},{"issue":"510","key":"10683_CR24","doi-asserted-by":"publisher","first-page":"eaaw2050","DOI":"10.1126\/scitranslmed.aaw2050","volume":"11","author":"P Gao","year":"2019","unstructured":"Gao P, Li L, Yang L, Gui D, Zhang J, Han J, Wang J, Wang N, Lu J, Chen S, Hou L, Sun H, Xie L, Zhou J, Peng C, Lu Y, Peng X, Wang C, Miao J, Ozcan U, Huang Y, Jia W, Liu J (2019) Yin Yang 1 protein ameliorates diabetic nephropathy pathology through transcriptional repression of TGF\u03b21. Sci Transl Med 11(510):eaaw2050. https:\/\/doi.org\/10.1126\/scitranslmed.aaw2050","journal-title":"Sci Transl Med"},{"issue":"1\u20132","key":"10683_CR25","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41434-021-00289-z","volume":"30","author":"Q Gao","year":"2021","unstructured":"Gao Q, Wang S, Zhang Z (2021) E3 ubiquitin ligase SMURF2 prevents colorectal cancer by reducing the stability of the YY1 protein and inhibiting the SENP1\/c-myc axis. Gene Ther 30(1\u20132):51\u201363. https:\/\/doi.org\/10.1038\/s41434-021-00289-z","journal-title":"Gene Ther"},{"issue":"8","key":"10683_CR26","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1038\/sj.onc.1209080","volume":"25","author":"S Gordon","year":"2006","unstructured":"Gordon S, Akopyan G, Garban H, Bonavida B (2006) Transcription factor YY1: structure, function, and therapeutic implications in cancer biology. Oncogene 25(8):1125\u20131142. https:\/\/doi.org\/10.1038\/sj.onc.1209080","journal-title":"Oncogene"},{"issue":"33","key":"10683_CR27","doi-asserted-by":"publisher","first-page":"12165","DOI":"10.1073\/pnas.0402283101","volume":"101","author":"E Gr\u00f6nroos","year":"2004","unstructured":"Gr\u00f6nroos E, Terentiev AA, Punga T, Ericsson J (2004) YY1 inhibits the activation of the p53 tumor suppressor in response to genotoxic stress. Proc Natl Acad Sci USA 101(33):12165\u201312170. https:\/\/doi.org\/10.1073\/pnas.0402283101","journal-title":"Proc Natl Acad Sci USA"},{"key":"10683_CR28","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.omtn.2020.06.018","volume":"21","author":"Q Guo","year":"2020","unstructured":"Guo Q, Wang T, Yang Y, Gao L, Zhao Q, Zhang W, Xi T, Zheng L (2020) Transcriptional factor Yin Yang 1 promotes the stemness of breast cancer cells by suppressing miR-873-5p transcriptional activity. Mol Ther Nucleic Acids 21:527\u2013541. https:\/\/doi.org\/10.1016\/j.omtn.2020.06.018","journal-title":"Mol Ther Nucleic Acids"},{"issue":"24","key":"10683_CR29","doi-asserted-by":"publisher","first-page":"4694","DOI":"10.1158\/0008-5472.CAN-22-3444","volume":"82","author":"J Han","year":"2022","unstructured":"Han J, Meng J, Chen S, Wang X, Yin S, Zhang Q, Liu H, Qin R, Li Z, Zhong W, Zhang C, Zhang H, Tang Y, Gao W, Zhang X, Yang L, Liu Y, Zhou HG, Sun T, Yang C (2022) Correction: YY1 complex promotes quaking expression via super-enhancer binding during EMT of hepatocellular carcinoma. Cancer Res 82(24):4694. https:\/\/doi.org\/10.1158\/0008-5472.CAN-22-3444","journal-title":"Cancer Res"},{"issue":"7","key":"10683_CR103","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1158\/0008-5472.CAN-18-2238","volume":"79","author":"J Han","year":"2019","unstructured":"Han, J., Meng, J., Chen, S., Wang, X., Yin, S., Zhang, Q., Liu, H., Qin, R., Li, Z., Zhong, W., Zhang, C., Zhang, H., Tang, Y., Lin, T., Gao, W., Zhang, X., Yang, L., Liu, Y., Zhou, H.G., Sun, T., Yang, C (2019) YY1 Complex Promotes Quaking Expression via Super-Enhancer Binding during EMT of Hepatocellular Carcinoma. Cancer Res 79(7)1451-1464. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-2238","journal-title":"Cancer Res"},{"key":"10683_CR105","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-18-2238","author":"J Han","year":"2019","unstructured":"Han J, Meng J, Chen S, Wang X, Yin S, Zhang Q, Liu H, Qin R, Li Z, Zhong W, Zhang C, Zhang H, Tang Y, Lin T, Gao W, Zhang X, Yang L, Liu Y, Zhou HG, Sun T, Yang C (2019) YY1 Complex Promotes Quaking Expression via Super-Enhancer Binding during EMT of Hepatocellular Carcinoma. Cancer Res 79(7):1451\u20131464. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-2238","journal-title":"Cancer Res"},{"issue":"1","key":"10683_CR30","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s13287-016-0360-x","volume":"7","author":"N He","year":"2016","unstructured":"He N, Feng G, Li Y, Xu Y, Xie X, Wang H, Wang Y, Ou L, Pei X, Liu N, Li Z (2016) Embryonic stem cell preconditioned microenvironment suppresses tumorigenic properties in breast cancer. Stem Cell Res Ther 7(1):95. https:\/\/doi.org\/10.1186\/s13287-016-0360-x","journal-title":"Stem Cell Res Ther"},{"key":"10683_CR104","doi-asserted-by":"crossref","unstructured":"Hernandez-Cueto, A., Hernandez-Cueto, D., Antonio-Andres, G., Mendoza-Marin, M., Jimenez-Gutierrez, C., Sandoval-Mejia, A.L., Mora-Campos, R., Gonzalez-Bonilla, C., Vega, M.I., Bonavida, B., Huerta-Yepez, S (2014) Death receptor 5 expression is inversely correlated with prostate cancer progression. Mol Med Rep 10(5) :2279-2286. }","DOI":"10.3892\/mmr.2014.2504"},{"key":"10683_CR106","doi-asserted-by":"publisher","DOI":"10.3892\/MMR.2014.2504","author":"A Hernandez-Cueto","year":"2014","unstructured":"Hernandez-Cueto A, Hernandez-Cueto D, Antonio-Andres G, Mendoza-Marin M, Jimenez-Gutierrez C, Sandoval-Mejia AL, Mora-Campos R, Gonzalez-Bonilla C, Vega MI, Bonavida B, Huerta-Yepez S (2014) Death receptor 5 expression is inversely correlated with prostate cancer progression. Mol Med Rep 10(5):2279\u20132286. https:\/\/doi.org\/10.3892\/MMR.2014.2504","journal-title":"Mol Med Rep"},{"issue":"4","key":"10683_CR31","doi-asserted-by":"publisher","first-page":"5738","DOI":"10.3892\/mmr.2017.7234","volume":"16","author":"A Hernandez-Cueto","year":"2017","unstructured":"Hernandez-Cueto A, Hernandez-Cueto D, Antonio-Andres G, Mendoza-Marin M, Jimenez-Gutierrez C, Sandoval-Mejia AL, Mora-Campos R, Gonzalez-Bonilla C, Vega MI, Bonavida B, Huerta-Yepez S (2017) [Corrigendum] Death receptor 5 expression is inversely correlated with prostate cancer progression. Mol Med Rep 16(4):5738. https:\/\/doi.org\/10.3892\/mmr.2017.7234","journal-title":"Mol Med Rep"},{"issue":"24","key":"10683_CR32","doi-asserted-by":"publisher","first-page":"13577","DOI":"10.1073\/pnas.93.24.13577","volume":"93","author":"HB Houbaviy","year":"1996","unstructured":"Houbaviy HB, Usheva A, Shenk T, Burley SK (1996) Cocrystal structure of YY1 bound to the adeno-associated virus P5 initiator. Proc Natl Acad Sci USA 93(24):13577\u201313582. https:\/\/doi.org\/10.1073\/pnas.93.24.13577","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"10683_CR33","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1089\/dna.2017.3857","volume":"36","author":"T Huang","year":"2017","unstructured":"Huang T, Wang G, Yang L, Peng B, Wen Y, Ding G, Wang Z (2017a) Transcription factor YY1 modulates lung cancer progression by activating lncRNA-PVT1. DNA Cell Biol 36(11):947\u2013958. https:\/\/doi.org\/10.1089\/dna.2017.3857","journal-title":"DNA Cell Biol"},{"issue":"2","key":"10683_CR34","doi-asserted-by":"publisher","first-page":"421","DOI":"10.3892\/ijo.2017.3840","volume":"50","author":"Y Huang","year":"2017","unstructured":"Huang Y, Tao T, Liu C, Guan H, Zhang G, Ling Z, Zhang L, Lu K, Chen S, Xu B, Chen M (2017b) Upregulation of miR-146a by YY1 depletion correlates with delayed progression of prostate cancer. Int J Oncol 50(2):421\u2013431. https:\/\/doi.org\/10.3892\/ijo.2017.3840","journal-title":"Int J Oncol"},{"key":"10683_CR37","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.niox.2012.12.001","volume":"29","author":"S Huerta-Yepez","year":"2012","unstructured":"Huerta-Yepez S, Baritaki S, Baay-Guzman G, Hernandez-Luna MA, Hernandez-Cueto A, Vega MI, Bonavida B (2012) Contribution of either YY1 or BclXL-induced inhibition by the NO-donor DETANONOate in the reversal of drug resistance, both in vitro and in vivo. YY1 and BclXL are overexpressed in prostate cancer. Nitric Oxide 29:17\u201324. https:\/\/doi.org\/10.1016\/j.niox.2012.12.001","journal-title":"Nitric Oxide"},{"issue":"1","key":"10683_CR36","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.niox.2008.08.001","volume":"20","author":"S Huerta-Yepez","year":"2009","unstructured":"Huerta-Yepez S, Vega M, Escoto-Chavez SE, Murdock B, Sakai T, Baritaki S, Bonavida B (2009) Nitric oxide sensitizes tumor cells to TRAIL-induced apoptosis via inhibition of the DR5 transcription repressor Yin Yang 1. Nitric Oxide 20(1):39\u201352. https:\/\/doi.org\/10.1016\/j.niox.2008.08.001","journal-title":"Nitric Oxide"},{"issue":"3","key":"10683_CR35","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.clim.2006.03.015","volume":"120","author":"S Huerta-Yepez","year":"2006","unstructured":"Huerta-Yepez S, Vega M, Garban H, Bonavida B (2006) Involvement of the TNF-alpha autocrine-paracrine loop, via NF-kappaB and YY1, in the regulation of tumor cell resistance to Fas-induced apoptosis. Clin Immunol 120(3):297\u2013309. https:\/\/doi.org\/10.1016\/j.clim.2006.03.015","journal-title":"Clin Immunol"},{"issue":"7","key":"10683_CR38","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1002\/ijc.29663","volume":"138","author":"K Inoue","year":"2015","unstructured":"Inoue K, Fry EA, Frazier DP (2015) Transcription factors that interact with p53 and Mdm2. Int J Cancer 138(7):1577\u20131585. https:\/\/doi.org\/10.1002\/ijc.29663","journal-title":"Int J Cancer"},{"issue":"5","key":"10683_CR39","doi-asserted-by":"publisher","first-page":"101223","DOI":"10.1016\/j.jbc.2021.101223","volume":"297","author":"Y Ishii","year":"2021","unstructured":"Ishii Y, Kolluri KK, Pennycuick A, Zhang X, Nigro E, Alrifai D, Borg E, Falzon M, Shah K, Kumar N, Janes SM (2021) BAP1 and YY1 regulate expression of death receptors in malignant pleural mesothelioma. J Biol Chem 297(5):101223. https:\/\/doi.org\/10.1016\/j.jbc.2021.101223","journal-title":"J Biol Chem"},{"issue":"3-4","key":"10683_CR40","doi-asserted-by":"publisher","first-page":"71","DOI":"10.18632\/genesandcancer.12","volume":"5","author":"V Kashyap","year":"2014","unstructured":"Kashyap V, Bonavida B (2014) Role of YY1 in the pathogenesis of prostate cancer and correlation with bioinformatic data sets of gene expression. Genes Cancer 5(3\u20134):71\u201383. https:\/\/doi.org\/10.18632\/genesandcancer.12","journal-title":"Genes Cancer"},{"key":"10683_CR41","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13046-016-0359-2","volume":"35","author":"S Kaufhold","year":"2016","unstructured":"Kaufhold S, Garb\u00e1n H, Bonavida B (2016) Yin Yang 1 is associated with cancer stem cell transcription factors (SOX2, OCT4, BMI1) and clinical implication. J Exp Clin Cancer Res 35:84. https:\/\/doi.org\/10.1186\/s13046-016-0359-2","journal-title":"J Exp Clin Cancer Res"},{"issue":"3","key":"10683_CR42","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1002\/ijc.31255","volume":"143","author":"LM Khachigian","year":"2018","unstructured":"Khachigian LM (2018) The Yin and Yang of YY1 in tumor growth and suppression. Int J Cancer 143(3):460\u2013465. https:\/\/doi.org\/10.1002\/ijc.31255","journal-title":"Int J Cancer"},{"issue":"1","key":"10683_CR43","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41416-019-0650-z","volume":"122","author":"N Koundouros","year":"2020","unstructured":"Koundouros N, Poulogiannis G (2020) Reprogramming of fatty acid metabolism in cancer. Br J Cancer 122(1):4\u201322. https:\/\/doi.org\/10.1038\/s41416-019-0650-z","journal-title":"Br J Cancer"},{"key":"10683_CR44","doi-asserted-by":"publisher","first-page":"856963","DOI":"10.3389\/fonc.2022.856963","volume":"12","author":"D Kwiatkowska","year":"2022","unstructured":"Kwiatkowska D, Mazur E, Reich A (2022) YY1 is a key player in melanoma immunotherapy\/targeted treatment resistance. Front Oncol 12:856963. https:\/\/doi.org\/10.3389\/fonc.2022.856963","journal-title":"Front Oncol"},{"issue":"9","key":"10683_CR45","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1038\/s41588-024-01871-y","volume":"56","author":"JC Lam","year":"2024","unstructured":"Lam JC, Aboreden NG, Midla SC, Wang S, Huang A, Keller CA, Giardine B, Henderson KA, Hardison RC, Zhang H, Blobel GA (2024) YY1-controlled regulatory connectivity and transcription are influenced by the cell cycle. Nat Genet 56(9):1938\u20131952. https:\/\/doi.org\/10.1038\/s41588-024-01871-y","journal-title":"Nat Genet"},{"issue":"1","key":"10683_CR46","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/s41467-020-14374-1","volume":"11","author":"P Lee","year":"2020","unstructured":"Lee P, Malik D, Perkons N, Huangyang P, Khare S, Rhoades S, Gong YY, Burrows M, Finan JM, Nissim I, Gade TPF, Weljie AM, Simon MC (2020) Targeting glutamine metabolism slows soft tissue sarcoma growth. Nat Commun 11(1):498. https:\/\/doi.org\/10.1038\/s41467-020-14374-1","journal-title":"Nat Commun"},{"issue":"10","key":"10683_CR50","doi-asserted-by":"publisher","first-page":"18415","DOI":"10.1002\/jcb.29158","volume":"120","author":"F Liang","year":"2019","unstructured":"Liang F, Fu X, Wang L (2019) miR-5590-3p-YY1 feedback loop promotes the proliferation and migration of triple-negative breast cancer cells. J Cell Biochem 120(10):18415\u201318424. https:\/\/doi.org\/10.1002\/jcb.29158","journal-title":"J Cell Biochem"},{"issue":"11","key":"10683_CR48","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1038\/s41419-022-05435-y","volume":"13","author":"M Li","year":"2022","unstructured":"Li M, Li M, Xia Y, Li G, Su X, Wang D, Ye J, Lu F, Sun T, Ji C (2022) HDAC1\/3-dependent moderate liquid\u2013liquid phase separation of YY1 promotes METTL3 expression and AML cell proliferation. Cell Death Dis 13(11):992. https:\/\/doi.org\/10.1038\/s41419-022-05435-y","journal-title":"Cell Death Dis"},{"issue":"10","key":"10683_CR52","doi-asserted-by":"publisher","first-page":"e1422","DOI":"10.1002\/ctm2.1422","volume":"13","author":"RJ Liu","year":"2023","unstructured":"Liu RJ, Xu ZP, Huang X, Xu B, Chen M (2023) Yin Yang 1 promotes the neuroendocrine differentiation of prostate cancer cells via the non-canonical WNT pathway (FYN\/STAT3). Clin Transl Med 13(10):e1422. https:\/\/doi.org\/10.1002\/ctm2.1422","journal-title":"Clin Transl Med"},{"issue":"13","key":"10683_CR51","doi-asserted-by":"publisher","first-page":"3616","DOI":"10.1111\/jcmm.17336","volume":"26","author":"Y Liu","year":"2022","unstructured":"Liu Y, Gao J, Xu M, Zhou Q, Zhang Z, Ye J, Li R (2022) Circular RNA circ-RCCD promotes cardiomyocyte differentiation in mouse embryo development via recruiting YY1 to the promoter of MyD88. J Cell Mol Med 26(13):3616\u20133627. https:\/\/doi.org\/10.1111\/jcmm.17336","journal-title":"J Cell Mol Med"},{"key":"10683_CR49","doi-asserted-by":"publisher","first-page":"6261","DOI":"10.1038\/s41467-025-61560-0","volume":"16","author":"W Li","year":"2025","unstructured":"Li W, Chen S, Lu J et al (2025) YY1 enhances HIF-1\u03b1 stability in tumor-associated macrophages to suppress anti-tumor immunity of prostate cancer in mice. Nat Commun 16:6261. https:\/\/doi.org\/10.1038\/s41467-025-61560-0","journal-title":"Nat Commun"},{"issue":"4","key":"10683_CR47","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1002\/path.2873","volume":"224","author":"Y Li","year":"2011","unstructured":"Li Y, Wang F, Xu J, Ye F, Shen Y, Zhou J, Lu W, Wan X, Ma D, Xie X (2011) Progressive miRNA expression profiles in cervical carcinogenesis and identification of HPV-related target genes for miR-29. J Pathol 224(4):484\u2013495. https:\/\/doi.org\/10.1002\/path.2873","journal-title":"J Pathol"},{"issue":"9","key":"10683_CR54","doi-asserted-by":"publisher","first-page":"4697","DOI":"10.26355\/eurrev_202005_21158","volume":"24","author":"ZF Luo","year":"2020","unstructured":"Luo ZF, Peng Y, Liu FH, Ma JS, Hu G, Lai SL, Lin H, Chen JJ, Zou GM, Yan Q, Sui WG (2020) Long noncoding RNA SNHG14 promotes malignancy of prostate cancer by regulating with miR-5590-3p\/YY1 axis. Eur Rev Med Pharmacol Sci 24(9):4697\u20134709. https:\/\/doi.org\/10.26355\/eurrev_202005_21158","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"6","key":"10683_CR53","doi-asserted-by":"publisher","first-page":"3309","DOI":"10.3892\/etm.2017.4387","volume":"13","author":"S Lu","year":"2017","unstructured":"Lu S, Wang M-S, Chen P-J, Ren Q, Bai P (2017) miRNA-186 inhibits prostate cancer cell proliferation and tumor growth by targeting YY1 and CDK6. Exp Ther Med 13(6):3309\u20133314. https:\/\/doi.org\/10.3892\/etm.2017.4387","journal-title":"Exp Ther Med"},{"key":"10683_CR55","doi-asserted-by":"publisher","first-page":"4878","DOI":"10.1038\/ncomms5878","volume":"5","author":"M Makhlouf","year":"2014","unstructured":"Makhlouf M, Ouimette JF, Oldfield A, Navarro P, Neuillet D, Rougeulle C (2014) A prominent and conserved role for YY1 in Xist transcriptional activation. Nat Commun 5:4878. https:\/\/doi.org\/10.1038\/ncomms5878","journal-title":"Nat Commun"},{"key":"10683_CR56","doi-asserted-by":"publisher","first-page":"106661","DOI":"10.1016\/j.phrs.2023.106661","volume":"188","author":"J Meng","year":"2023","unstructured":"Meng J, Han J, Wang X, Wu T, Zhang H, An H, Qin L, Sun Y, Zhong W, Yang C, Liu H, Sun T (2023) Twist1-YY1-p300 complex promotes the malignant progression of HCC through activation of miR-9 by forming phase-separated condensates at super-enhancers and relieved by metformin. Pharmacol Res 188:106661. https:\/\/doi.org\/10.1016\/j.phrs.2023.106661","journal-title":"Pharmacol Res"},{"issue":"22","key":"10683_CR57","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.18632\/oncotarget.26745","volume":"10","author":"M Morales-Martinez","year":"2019","unstructured":"Morales-Martinez M, Valencia-Hipolito A, Vega GG, Neri N, Nambo MJ, Alvarado I, Cuadra I, Duran-Padilla MA, Martinez-Maza O, Huerta-Yepez S, Vega MI (2019) Regulation of Kr\u00fcppel-like factor 4 (KLF4) expression through the transcription factor Yin-Yang 1 (YY1) in non-Hodgkin B-cell lymphoma. Oncotarget 10(22):2173\u20132188. https:\/\/doi.org\/10.18632\/oncotarget.26745","journal-title":"Oncotarget"},{"key":"10683_CR58","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2005.23.16_suppl.3189","author":"M Neshat","year":"2005","unstructured":"Neshat M, Baritaki S, Huerta-Yepez S, Katsman A, Delgado T, Umezawa K, Sakai T, Yeung KC, Chatterjee D, Bonavida B (2005) Sensitization of prostate cancer cells to TRAIL-induced apoptosis by CDDP: involvement of NF-\u03baB, YY1 and RKIP in upregulation of DR5 expression. J Clin Oncol. https:\/\/doi.org\/10.1200\/jco.2005.23.16_suppl.3189","journal-title":"J Clin Oncol"},{"key":"10683_CR59","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.ctrv.2017.04.003","volume":"56","author":"R O\u2019Brien","year":"2017","unstructured":"O\u2019Brien R, Marignol L (2017) The Notch-1 receptor in prostate tumorigenesis. Cancer Treat Rev 56:36\u201346. https:\/\/doi.org\/10.1016\/j.ctrv.2017.04.003","journal-title":"Cancer Treat Rev"},{"issue":"9","key":"10683_CR60","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.3390\/cancers11091343","volume":"11","author":"M Ocker","year":"2019","unstructured":"Ocker M, Al Bitar S, Monteiro AC, Gali-Muhtasib H, Schneider-Stock R (2019) Epigenetic regulation of p21cip1\/waf1 in human cancer. Cancers 11(9):1343. https:\/\/doi.org\/10.3390\/cancers11091343","journal-title":"Cancers"},{"issue":"12","key":"10683_CR61","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.7150\/jca.19036","volume":"8","author":"A Park","year":"2017","unstructured":"Park A, Lee J, Mun S, Kim DJ, Cha BH, Moon KT, Yoo TK, Kang HG (2017) Identification of transcription factor YY1 as a regulator of a prostate cancer-specific pathway using proteomic analysis. J Cancer 8(12):2303\u20132311. https:\/\/doi.org\/10.7150\/jca.19036","journal-title":"J Cancer"},{"issue":"14","key":"10683_CR62","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.4161\/cbt.8.14.8880","volume":"8","author":"BL Petrella","year":"2009","unstructured":"Petrella BL, Brinckerhoff CE (2009) PTEN suppression of YY1 induces HIF-2 activity in von-Hippel-Lindau-null renal-cell carcinoma. Cancer Biol Ther 8(14):1389\u20131401. https:\/\/doi.org\/10.4161\/cbt.8.14.8880","journal-title":"Cancer Biol Ther"},{"issue":"11","key":"10683_CR63","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1038\/s41375-019-0472-2","volume":"33","author":"DA Pollyea","year":"2019","unstructured":"Pollyea DA, Tallman MS, de Botton S, Kantarjian HM, Collins R, Stein AS, Frattini MG, Xu Q, Tosolini A, See WL, MacBeth KJ, Agresta SV, Attar EC, DiNardo CD, Stein EM (2019) Enasidenib, an inhibitor of mutant IDH2 proteins, induces durable remissions in older patients with newly diagnosed acute myeloid leukemia. Leukemia 33(11):2575\u20132584. https:\/\/doi.org\/10.1038\/s41375-019-0472-2","journal-title":"Leukemia"},{"issue":"6","key":"10683_CR64","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1002\/cam4.1073","volume":"6","author":"S-Y Qu","year":"2017","unstructured":"Qu S-Y, Sun Y-Y, Li Y-H, Xu Z-M, Fu W-N (2017) YY1 directly suppresses MYCT1 leading to laryngeal tumorigenesis and progress. Cancer Med 6(6):1389\u20131398. https:\/\/doi.org\/10.1002\/cam4.1073","journal-title":"Cancer Med"},{"issue":"1","key":"10683_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-020-00243-0","volume":"7","author":"RJ Rebello","year":"2021","unstructured":"Rebello RJ, Oing C, Knudsen KE, Loeb S, Johnson DC, Reiter RE, Gillessen S, Van der Kwast T, Bristow RG (2021) Prostate cancer. Nat Rev Dis Primers 7(1):9. https:\/\/doi.org\/10.1038\/s41572-020-00243-0","journal-title":"Nat Rev Dis Primers"},{"issue":"5","key":"10683_CR66","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/j.biocel.2008.10.015","volume":"41","author":"G Ren","year":"2008","unstructured":"Ren G, Zhang G, Dong Z, Liu Z, Li L, Feng Y, Su D, Zhang Y, Huang B, Lu J (2008) Recruitment of HDAC4 by transcription factor YY1 represses HOXB13 to affect cell growth in AR-negative prostate cancers. Int J Biochem Cell Biol 41(5):1094\u20131101. https:\/\/doi.org\/10.1016\/j.biocel.2008.10.015","journal-title":"Int J Biochem Cell Biol"},{"issue":"12","key":"10683_CR67","doi-asserted-by":"publisher","first-page":"7487","DOI":"10.1128\/mcb.13.12.7487-7495.1993","volume":"13","author":"KJ Riggs","year":"1993","unstructured":"Riggs KJ, Saleque S, Wong KK, Merrell KT, Lee JS, Shi Y, Calame K (1993) Yin-yang 1 activates the c-myc promoter. Mol Cell Biol 13(12):7487\u20137495. https:\/\/doi.org\/10.1128\/mcb.13.12.7487-7495.1993","journal-title":"Mol Cell Biol"},{"issue":"1","key":"10683_CR68","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13046-020-01551-9","volume":"39","author":"Z Rong","year":"2020","unstructured":"Rong Z, Wang Z, Wang X, Qin C, Geng W (2020) Molecular interplay between linc01134 and YY1 dictates hepatocellular carcinoma progression. J Exp Clin Cancer Res 39(1):61. https:\/\/doi.org\/10.1186\/s13046-020-01551-9","journal-title":"J Exp Clin Cancer Res"},{"issue":"43","key":"10683_CR69","doi-asserted-by":"publisher","first-page":"5717","DOI":"10.1038\/onc.2008.181","volume":"27","author":"N Sankar","year":"2008","unstructured":"Sankar N, Baluchamy S, Kadeppagari RK, Singhal G, Weitzman S, Thimmapaya B (2008) p300 provides a corepressor function by cooperating with YY1 and HDAC3 to repress c-Myc. Oncogene 27(43):5717\u20135728. https:\/\/doi.org\/10.1038\/onc.2008.181","journal-title":"Oncogene"},{"issue":"5","key":"10683_CR70","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3892\/or.2022.8298","volume":"47","author":"N Sato","year":"2022","unstructured":"Sato N, Sakai N, Furukawa K, Takayashiki T, Kuboki S, Takano S, Ohira G, Matsubara H, Ohtsuka M (2022) Yin Yang 1 regulates ITGAV and ITGB1, contributing to improved prognosis of colorectal cancer. Oncol Rep 47(5):87. https:\/\/doi.org\/10.3892\/or.2022.8298","journal-title":"Oncol Rep"},{"issue":"1","key":"10683_CR71","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3892\/ijo.27.1.131","volume":"27","author":"D Seligson","year":"2005","unstructured":"Seligson D, Horvath S, Huerta-Yepez S, Hanna S, Garban H, Roberts A, Shi T, Liu X, Chia D, Goodglick L, Bonavida B (2005) Expression of transcription factor Yin Yang 1 in prostate cancer. Int J Oncol 27(1):131\u2013141. https:\/\/doi.org\/10.3892\/ijo.27.1.131","journal-title":"Int J Oncol"},{"issue":"10\u201311","key":"10683_CR72","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1038\/s41417-020-00254-9","volume":"28","author":"B Shen","year":"2020","unstructured":"Shen B, Li Y, Ye Q, Qin Y (2020) YY1-mediated long non-coding RNA Kcnq1ot1 promotes the tumor progression by regulating PTEN via DNMT1 in triple negative breast cancer. Cancer Gene Ther 28(10\u201311):1099\u20131112. https:\/\/doi.org\/10.1038\/s41417-020-00254-9","journal-title":"Cancer Gene Ther"},{"issue":"20","key":"10683_CR73","doi-asserted-by":"publisher","first-page":"10638","DOI":"10.1073\/pnas.93.20.10638","volume":"93","author":"Yu Shrivastava","year":"1996","unstructured":"Shrivastava Yu, Artandi C (1996) YY1 and c-Myc associate in vivo in a manner that depends on c-Myc levels. Proc Natl Acad Sci USA 93(20):10638\u201310641. https:\/\/doi.org\/10.1073\/pnas.93.20.10638","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"10683_CR74","doi-asserted-by":"publisher","first-page":"157","DOI":"10.4255\/mcpharmacol.09.20","volume":"1","author":"G Sui","year":"2009","unstructured":"Sui G (2009) The regulation of YY1 in tumorigenesis and its targeting potential in cancer therapy. Mol Cell Pharmacol 1(3):157\u2013176. https:\/\/doi.org\/10.4255\/mcpharmacol.09.20","journal-title":"Mol Cell Pharmacol"},{"issue":"4","key":"10683_CR75","doi-asserted-by":"publisher","first-page":"e35570","DOI":"10.1371\/journal.pone.0035570","volume":"7","author":"S Tang","year":"2012","unstructured":"Tang S, Mishra M, Frazier DP, Moore ML, Inoue K, Deora R, Sui G, Dubey P (2012) Positive and negative regulation of prostate stem cell antigen expression by Yin Yang 1 in prostate epithelial cell lines. PLoS ONE 7(4):e35570. https:\/\/doi.org\/10.1371\/journal.pone.0035570","journal-title":"PLoS ONE"},{"key":"10683_CR76","doi-asserted-by":"publisher","first-page":"155467","DOI":"10.1016\/j.prp.2024.155467","volume":"260","author":"A Taskiran","year":"2024","unstructured":"Taskiran A, Oktem G, Demir A, Oltulu F, Ozcinar E, Duzagac F, Guven U, Karakoc E, Cakir A, Ayla S, Guven S, Acikgoz E (2024) Embryonic microenvironment suppresses YY1 and YY1-related genes in prostate cancer stem cells. Pathol Res Pract 260:155467. https:\/\/doi.org\/10.1016\/j.prp.2024.155467","journal-title":"Pathol Res Pract"},{"issue":"3","key":"10683_CR77","first-page":"212","volume":"45","author":"W Ting","year":"2021","unstructured":"Ting W, Qianqian GUO, Yue Y, Lufeng Z, Tao XI (2021) Advances in research on the role of Yin Yang 1 in tumor progression. Progress Pharm Sci 45(3):212\u2013221","journal-title":"Progress Pharm Sci"},{"issue":"9","key":"10683_CR78","doi-asserted-by":"publisher","first-page":"e12887","DOI":"10.1111\/cpr.12887","volume":"53","author":"C Tu","year":"2020","unstructured":"Tu C, Yang K, Wan L, He J, Qi L, Wang W, Lu Q, Li Z (2020) The crosstalk between lncRNAs and the Hippo signalling pathway in cancer progression. Cell Prolif 53(9):e12887. https:\/\/doi.org\/10.1111\/cpr.12887","journal-title":"Cell Prolif"},{"key":"10683_CR79","doi-asserted-by":"publisher","first-page":"718947","DOI":"10.3389\/fcell.2021.718947","volume":"9","author":"M Tufano","year":"2021","unstructured":"Tufano M, Cesaro E, Martinelli R, Pacelli R, Romano S, Romano MF (2021) FKBP51 affects TNF-related apoptosis inducing ligand response in melanoma. Front Cell Dev Biol 9:718947. https:\/\/doi.org\/10.3389\/fcell.2021.718947","journal-title":"Front Cell Dev Biol"},{"issue":"4","key":"10683_CR80","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.4049\/jimmunol.175.4.2174","volume":"175","author":"MI Vega","year":"2005","unstructured":"Vega MI, Jazirehi AR, Huerta-Yepez S, Bonavida B (2005) Rituximab-induced inhibition of YY1 and Bcl-xL expression in Ramos non-Hodgkin\u2019s lymphoma cell line via inhibition of NF-kappa B activity: role of YY1 and Bcl-xL in Fas resistance and chemoresistance, respectively. J Immunol 175(4):2174\u20132183. https:\/\/doi.org\/10.4049\/jimmunol.175.4.2174","journal-title":"J Immunol"},{"issue":"13","key":"10683_CR83","doi-asserted-by":"publisher","first-page":"5002","DOI":"10.18632\/oncotarget.2073","volume":"5","author":"A-M Wang","year":"2014","unstructured":"Wang A-M, Huang T-T, Hsu K-W, Huang K-H, Fang W-L, Yang M-H, Lo S-S, Chi C-W, Lin J-J, Yeh T-S (2014) Yin Yang 1 is a target of microRNA-34 family and contributes to gastric carcinogenesis. Oncotarget 5(13):5002\u20135016. https:\/\/doi.org\/10.18632\/oncotarget.2073","journal-title":"Oncotarget"},{"issue":"31","key":"10683_CR81","doi-asserted-by":"publisher","first-page":"18701","DOI":"10.1073\/pnas.2005726117","volume":"117","author":"GZ Wang","year":"2020","unstructured":"Wang GZ, Goff SP (2020) Yin Yang 1 is a potent activator of human T lymphotropic virus type 1 LTR-driven gene expression via RNA binding. Proc Natl Acad Sci USA 117(31):18701\u201318710. https:\/\/doi.org\/10.1073\/pnas.2005726117","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"10683_CR82","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.ccr.2008.10.006","volume":"14","author":"H Wang","year":"2008","unstructured":"Wang H, Garzon R, Sun H, Ladner KJ, Singh R, Dahlman J, Cheng A, Hall BM, Qualman SJ, Chandler DS, Croce CM, Guttridge DC (2008) NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma. Cancer Cell 14(5):369\u2013381. https:\/\/doi.org\/10.1016\/j.ccr.2008.10.006","journal-title":"Cancer Cell"},{"issue":"2","key":"10683_CR84","doi-asserted-by":"publisher","first-page":"e0193340","DOI":"10.1371\/journal.pone.0193340","volume":"13","author":"W Wang","year":"2018","unstructured":"Wang W, Yue Z, Tian Z, Xie Y, Zhang J, She Y, Yang B, Ye Y, Yang Y (2018) Expression of Yin Yang 1 in cervical cancer and its correlation with E-cadherin expression and HPV16 E6. PLoS ONE 13(2):e0193340. https:\/\/doi.org\/10.1371\/journal.pone.0193340","journal-title":"PLoS ONE"},{"issue":"1","key":"10683_CR85","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s13059-023-02931-y","volume":"24","author":"X Wang","year":"2023","unstructured":"Wang X, Fan W, Li N, Ma Y, Yao M, Wang G, He S, Li W, Tan J, Lu Q, Hou S (2023) YY1 lactylation in microglia promotes angiogenesis through transcription activation-mediated upregulation of FGF2. Genome Biol 24(1):87. https:\/\/doi.org\/10.1186\/s13059-023-02931-y","journal-title":"Genome Biol"},{"key":"10683_CR86","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.drup.2017.01.001","volume":"30","author":"S Wottrich","year":"2017","unstructured":"Wottrich S, Kaufhold S, Chrysos E, Zoras O, Baritaki S, Bonavida B (2017) Inverse correlation between the metastasis suppressor RKIP and the metastasis inducer YY1: contrasting roles in the regulation of chemo\/immuno-resistance in cancer. Drug Resist Updat 30:28\u201338. https:\/\/doi.org\/10.1016\/j.drup.2017.01.001","journal-title":"Drug Resist Updat"},{"issue":"9","key":"10683_CR87","doi-asserted-by":"publisher","first-page":"4971","DOI":"10.1093\/nar\/gkab252","volume":"49","author":"C Xu","year":"2021","unstructured":"Xu C, Tsai Y-H, Galbo PM, Gong W, Storey AJ, Xu Y, Byrum SD, Xu L, Whang YE, Parker JS, Mackintosh SG, Edmondson RD, Tackett AJ, Huang J, Zheng D, Earp HS, Wang GG, Cai L (2021) Cistrome analysis of YY1 uncovers a regulatory axis of YY1:BRD2\/4-PFKP during tumorigenesis of advanced prostate cancer. Nucleic Acids Res 49(9):4971\u20134988. https:\/\/doi.org\/10.1093\/nar\/gkab252","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"10683_CR88","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.bbrc.2004.04.065","volume":"318","author":"T Yakovleva","year":"2004","unstructured":"Yakovleva T, Kolesnikova L, Vukojevi\u0107 V, Gileva I, Tan-No K, Austen M, L\u00fcscher B, Ekstr\u00f6m TJ, Terenius L, Bakalkin G (2004) YY1 binding to a subset of p53 DNA-target sites regulates p53-dependent transcription. Biochem Biophys Res Commun 318(2):615\u2013624. https:\/\/doi.org\/10.1016\/j.bbrc.2004.04.065","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"10683_CR89","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s12967-017-1308-3","volume":"15","author":"C Yang","year":"2017","unstructured":"Yang C, Zhang J-J, Peng Y-P, Zhu Y, Yin L-D, Wei J-S, Gao W-T, Jiang K-R, Miao Y (2017) A yin-yang 1\/miR-30a regulatory circuit modulates autophagy in pancreatic cancer cells. J Transl Med 15(1):211. https:\/\/doi.org\/10.1186\/s12967-017-1308-3","journal-title":"J Transl Med"},{"issue":"1","key":"10683_CR90","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s12964-019-0457-9","volume":"17","author":"N Yang","year":"2019","unstructured":"Yang N, Liu S, Qin T, Liu X, Watanabe N, Mayo KH, Li J, Li X (2019a) SUMO3 modification by PIAS1 modulates androgen receptor cellular distribution and stability. Cell Commun Signal 17(1):153. https:\/\/doi.org\/10.1186\/s12964-019-0457-9","journal-title":"Cell Commun Signal"},{"issue":"11","key":"10683_CR91","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1002\/pros.23790","volume":"79","author":"T Yang","year":"2019","unstructured":"Yang T, An Z, Zhang C, Wang Z, Wang X, Liu Y, Du E, Liu R, Zhang Z, Xu Y (2019b) HnRNPM, a potential mediator of YY1 in promoting the epithelial-mesenchymal transition of prostate cancer cells. Prostate 79(11):1199\u20131210. https:\/\/doi.org\/10.1002\/pros.23790","journal-title":"Prostate"},{"key":"10683_CR92","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.metabol.2019.04.013","volume":"96","author":"T Yang","year":"2019","unstructured":"Yang T, Shu F, Yang H, Heng C, Zhou Y, Chen Y, Qian X, Du L, Zhu X, Lu Q, Yin X (2019c) YY1: a novel therapeutic target for diabetic nephropathy orchestrated renal fibrosis. Metabolism 96:33\u201345. https:\/\/doi.org\/10.1016\/j.metabol.2019.04.013","journal-title":"Metabolism"},{"issue":"8","key":"10683_CR93","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.trecan.2021.04.003","volume":"7","author":"WH Yang","year":"2021","unstructured":"Yang WH, Qiu Y, Stamatatos O, Janowitz T, Lukey MJ (2021) Enhancing the efficacy of glutamine metabolism inhibitors in cancer therapy. Trends Cancer 7(8):790\u2013804. https:\/\/doi.org\/10.1016\/j.trecan.2021.04.003","journal-title":"Trends Cancer"},{"issue":"21","key":"10683_CR94","doi-asserted-by":"publisher","first-page":"4353","DOI":"10.1093\/nar\/23.21.4353","volume":"23","author":"SR Yant","year":"1995","unstructured":"Yant SR, Zhu W, Millinoff D, Slightom JL, Goodman M, Gumucio DL (1995) High affinity YY1 binding motifs: identification of two core types (ACAT and CCAT) and distribution of potential binding sites within the human beta globin cluster. Nucleic Acids Res 23(21):4353\u20134362. https:\/\/doi.org\/10.1093\/nar\/23.21.4353","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"10683_CR95","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.prnil.2016.05.001","volume":"4","author":"S Yoo","year":"2016","unstructured":"Yoo S, Choi SY, You D, Kim C-S (2016) New drugs in prostate cancer. Prostate Int 4(2):37\u201342. https:\/\/doi.org\/10.1016\/j.prnil.2016.05.001","journal-title":"Prostate Int"},{"issue":"5","key":"10683_CR96","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/s41417-022-00580-0","volume":"30","author":"J You","year":"2022","unstructured":"You J, Tao B, Peng L, Peng T, He H, Zeng S, Han J, Chen L, Xia X, Yang X, Zhong C (2022) Transcription factor YY1 mediates self-renewal of glioblastoma stem cells through regulation of the SENP1\/METTL3\/MYC axis. Cancer Gene Ther 30(5):683\u2013693. https:\/\/doi.org\/10.1038\/s41417-022-00580-0","journal-title":"Cancer Gene Ther"},{"key":"10683_CR98","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.canlet.2017.08.032","volume":"408","author":"J-J Zhang","year":"2017","unstructured":"Zhang J-J, Zhu Y, Zhang X-F, Liu D-F, Wang Y, Yang C, Shi G-D, Peng Y-P, Zhang K, Tian L, Miao Y, Jiang K-R (2017) Yin yang-1 suppresses pancreatic ductal adenocarcinoma cell proliferation and tumor growth by regulating SOX2OT-SOX2 axis. Cancer Lett 408:144\u2013154. https:\/\/doi.org\/10.1016\/j.canlet.2017.08.032","journal-title":"Cancer Lett"},{"issue":"42","key":"10683_CR97","doi-asserted-by":"publisher","first-page":"5078","DOI":"10.1038\/onc.2012.526","volume":"32","author":"N Zhang","year":"2013","unstructured":"Zhang N, Li X, Wu CW, Dong Y, Cai M, Mok MTS, Wang H, Chen J, Ng SSM, Chen M, Sung JJY, Yu J (2013) MicroRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis. Oncogene 32(42):5078\u20135088. https:\/\/doi.org\/10.1038\/onc.2012.526","journal-title":"Oncogene"},{"issue":"6","key":"10683_CR100","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.3892\/ijo.2016.3718","volume":"49","author":"H Zhou","year":"2016","unstructured":"Zhou H, Li J, Zhang Z, Ye R, Shao N, Cheang T, Wang S (2016) RING1 and YY1 binding protein suppresses breast cancer growth and metastasis. Int J Oncol 49(6):2442\u20132452. https:\/\/doi.org\/10.3892\/ijo.2016.3718","journal-title":"Int J Oncol"},{"issue":"6","key":"10683_CR99","doi-asserted-by":"publisher","first-page":"4541","DOI":"10.3892\/mmr.2015.3324","volume":"11","author":"WY Zhou","year":"2015","unstructured":"Zhou WY, Chen JC, Jiao TT, Hui N, Qi X (2015) MicroRNA-181 targets Yin Yang 1 expression and inhibits cervical cancer progression. Mol Med Rep 11(6):4541\u20134546. https:\/\/doi.org\/10.3892\/mmr.2015.3324","journal-title":"Mol Med Rep"},{"issue":"2","key":"10683_CR101","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.apsb.2021.07.016","volume":"12","author":"X Zhou","year":"2022","unstructured":"Zhou X, Zou L, Liao H, Luo J, Yang T, Wu J, Chen W, Wu K, Cen S, Lv D, Shu F, Yang Y, Li C, Li B, Mao X (2022) Abrogation of HnRNP L enhances anti-PD-1 therapy efficacy via diminishing PD-L1 and promoting CD8(+) T cell-mediated ferroptosis in castration-resistant prostate cancer. Acta Pharm Sin B 12(2):692\u2013707. https:\/\/doi.org\/10.1016\/j.apsb.2021.07.016","journal-title":"Acta Pharm Sin B"}],"container-title":["Journal of Molecular Histology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10735-025-10683-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10735-025-10683-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10735-025-10683-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T06:25:38Z","timestamp":1772000738000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10735-025-10683-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,7]]},"references-count":105,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["10683"],"URL":"https:\/\/doi.org\/10.1007\/s10735-025-10683-1","relation":{},"ISSN":["1567-2379","1567-2387"],"issn-type":[{"value":"1567-2379","type":"print"},{"value":"1567-2387","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,7]]},"assertion":[{"value":"29 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read and agreed to the publication of this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"31"}}